CN111528480A - Calcium nutritional supplement and preparation method thereof - Google Patents
Calcium nutritional supplement and preparation method thereof Download PDFInfo
- Publication number
- CN111528480A CN111528480A CN202010435331.3A CN202010435331A CN111528480A CN 111528480 A CN111528480 A CN 111528480A CN 202010435331 A CN202010435331 A CN 202010435331A CN 111528480 A CN111528480 A CN 111528480A
- Authority
- CN
- China
- Prior art keywords
- calcium
- solution
- sericin
- reaction
- nutritional supplement
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000011575 calcium Substances 0.000 title claims abstract description 101
- 229910052791 calcium Inorganic materials 0.000 title claims abstract description 101
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title claims abstract description 92
- 235000015872 dietary supplement Nutrition 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 108010013296 Sericins Proteins 0.000 claims abstract description 51
- 238000006243 chemical reaction Methods 0.000 claims abstract description 28
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims abstract description 26
- 238000009835 boiling Methods 0.000 claims abstract description 26
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical class [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 claims abstract description 23
- 230000000694 effects Effects 0.000 claims abstract description 21
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 21
- 238000001694 spray drying Methods 0.000 claims abstract description 20
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 18
- 102000016387 Pancreatic elastase Human genes 0.000 claims abstract description 16
- 108010067372 Pancreatic elastase Proteins 0.000 claims abstract description 16
- 108091005658 Basic proteases Proteins 0.000 claims abstract description 15
- 229920000137 polyphosphoric acid Polymers 0.000 claims abstract description 14
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims abstract description 13
- 229910000029 sodium carbonate Inorganic materials 0.000 claims abstract description 13
- 229940083466 soybean lecithin Drugs 0.000 claims abstract description 13
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 13
- 239000002699 waste material Substances 0.000 claims abstract description 8
- 241000255789 Bombyx mori Species 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 34
- 238000001816 cooling Methods 0.000 claims description 18
- 229940069978 calcium supplement Drugs 0.000 claims description 17
- 238000006460 hydrolysis reaction Methods 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 15
- 238000003756 stirring Methods 0.000 claims description 9
- 239000012466 permeate Substances 0.000 claims description 3
- 238000010521 absorption reaction Methods 0.000 abstract description 16
- 239000000706 filtrate Substances 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 229910019142 PO4 Inorganic materials 0.000 abstract description 2
- 239000010452 phosphate Substances 0.000 abstract description 2
- 229960005069 calcium Drugs 0.000 description 92
- 238000002474 experimental method Methods 0.000 description 19
- 241000699670 Mus sp. Species 0.000 description 17
- 230000000052 comparative effect Effects 0.000 description 15
- 102000011632 Caseins Human genes 0.000 description 10
- 108010076119 Caseins Proteins 0.000 description 10
- 239000005018 casein Substances 0.000 description 7
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical group NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 7
- 235000021240 caseins Nutrition 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 6
- 229910052698 phosphorus Inorganic materials 0.000 description 6
- 239000011574 phosphorus Substances 0.000 description 6
- 108010001441 Phosphopeptides Proteins 0.000 description 5
- YUWBVKYVJWNVLE-UHFFFAOYSA-N [N].[P] Chemical compound [N].[P] YUWBVKYVJWNVLE-UHFFFAOYSA-N 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 4
- 230000026731 phosphorylation Effects 0.000 description 4
- 238000006366 phosphorylation reaction Methods 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
- 229910001385 heavy metal Inorganic materials 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 235000011007 phosphoric acid Nutrition 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229910052793 cadmium Inorganic materials 0.000 description 2
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 238000005034 decoration Methods 0.000 description 2
- 230000002550 fecal effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 235000021247 β-casein Nutrition 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 238000007696 Kjeldahl method Methods 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000001354 calcination Methods 0.000 description 1
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 1
- 239000001639 calcium acetate Substances 0.000 description 1
- 229960005147 calcium acetate Drugs 0.000 description 1
- 235000011092 calcium acetate Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 229960004256 calcium citrate Drugs 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229940078480 calcium levulinate Drugs 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 235000012255 calcium oxide Nutrition 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 231100000739 chronic poisoning Toxicity 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000009616 inductively coupled plasma Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical group OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 235000021249 α-casein Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention belongs to the field of biomedical engineering, and discloses a calcium nutritional supplement and a preparation method thereof. The preparation method provided by the invention comprises the following steps: (1) boiling silkworm cocoon or waste raw silk with sodium carbonate solution to degum to obtain sericin solution; (2) adding alkaline protease into sericin solution for reaction, adjusting the pH to 7.5 with hydrochloric acid, adding elastase for reaction, performing ultrafiltration, and spray-drying the filtrate to obtain sericin peptide; (3) and (3) dropwise adding polyphosphoric acid on sericin peptide, adding soybean lecithin for reaction, then adding a saturated calcium hydroxide solution to precipitate redundant phosphate radicals, centrifuging, taking supernate, and performing spray drying to obtain the calcium nutritional supplement. The calcium nutritional supplement prepared by the invention is rich in absorbable calcium and has the effect of promoting calcium absorption.
Description
Technical Field
The invention relates to the field of biomedical engineering, in particular to a calcium nutritional supplement and a preparation method thereof.
Background
At present, the raw materials of calcium supplement products on the market mainly comprise:
firstly, organic calcium: such as calcium gluconate, calcium lactate, calcium acetate, calcium citrate, calcium levulinate, etc. The organic calcium has high solubility and less irritation to stomach and intestine, but the content of calcium is less, and the absorption rate is about 10-15%.
II, inorganic calcium: such as calcium carbonate, calcium phosphate, calcium oxide, calcium hydrogen phosphate, etc., with an absorption rate of 30-40%. Inorganic calcium has low solubility and is more irritating to the stomach and intestine, but the content of calcium is relatively high.
Thirdly, active calcium: the active calcium is prepared from animal bone and shell by calcining at high temperature and electrolyzing, and mainly comprises calcium hydroxide and calcium chloride. Although the active calcium has high ionization degree and solubility, the bioavailability is not high, the calcium content is low, small-time liquid of the active calcium is strong alkaline (pH is more than 12), the acute toxicity is high, the stimulation to intestines and stomach is large, nausea, vomiting and the like are easily caused, and the content of heavy metals (lead, arsenic, cadmium and the like) in a calcium product is high.
Fourthly, biological calcium: the natural biological calcium is mainly prepared from oyster shells, shells and the like in the current market, and is sourced from lakes, offshore waters and other water areas. Due to the pollution problem of oceans and lakes, the pollution of elements such as lead, cadmium and the like in the calcium agent is reported. Oyster shell often contains various heavy metal elements, and long-term administration can cause the heavy metals to deposit in vivo to cause chronic poisoning.
In conclusion, the main sources of raw materials of the safer calcium supplement products in the market are organic calcium and inorganic calcium, but the organic calcium and the inorganic calcium generally have the problem of low calcium absorption rate, and the common solution is to promote the absorption and utilization of calcium by adding a calcium nutritional supplement. A commonly used calcium nutritional supplement is casein phosphopeptide (CPP), the core structure of which is: -Ser (P) -Glu-Glu- (Ser: serine, Glu: glutamic acid, P: phosphate). Phosphoserine residues (-Ser (P)) in the structure of the CPP exist in clusters, and are negatively charged in the intestinal tract pH weakly alkaline environment, so that the further action of digestive enzymes can be prevented, and the CPP can not be further hydrolyzed and stably exists in the intestine. Domestic researches find that the smaller the molar ratio of nitrogen to phosphorus in the CPP, the shorter the peptide chain of the CPP, and the higher the density of phosphate group, the higher the purity of the CPP, and the stronger the effect of promoting the absorption and utilization of calcium. However, CPP has limited phosphate groups bound to casein, especially beta-casein, contains a large amount of glutamine, forms a major phosphorylation site near the N-terminus, and has a smaller number of beta-casein phosphorylation sites and a smaller level of phosphorylation than alpha-casein, which greatly limits its calcium-holding ability.
Therefore, there is a need for a calcium supplement having a high calcium carrying capacity, which is effective in improving calcium absorption.
Disclosure of Invention
In view of the above, the present invention aims to provide a calcium supplement and a preparation method thereof, and the prepared calcium supplement has a low nitrogen-phosphorus ratio, a short peptide chain and a strong calcium carrying capacity.
In order to solve the technical problems, the invention provides a preparation method of a calcium nutritional supplement, which comprises the following steps:
s1, boiling silkworm cocoons or waste raw silks with sodium carbonate solution to obtain a sericin solution;
s2, adding alkaline protease into the sericin solution to perform a first-step hydrolysis reaction to obtain a first reaction solution, adjusting the pH of the first reaction solution to 7.5 by using 6mol/L hydrochloric acid, adding elastase to perform a second-step hydrolysis reaction, performing ultrafiltration, and performing spray drying on a permeate obtained by ultrafiltration to obtain sericin;
s3, dripping polyphosphoric acid on the sericin peptide, adding soybean lecithin, reacting for 5-8h at 20-50 ℃, adding water after the reaction is finished, cooling to room temperature after 20-30min of boiling water bath, slowly dripping saturated calcium hydroxide solution, fully stirring to determine the pH value, stopping adding the saturated calcium hydroxide solution when the pH value is increased and then reduced to 7.5, cooling to 4-8 ℃, centrifuging, taking supernate, and spray drying to obtain the calcium nutritional supplement.
Preferably, in step S1, the concentration of the sodium carbonate solution is 50-100g/L, the bath ratio of the water boiling is 1:40-1:60, and the time of the water boiling is 30-60 min.
Preferably, in step S2, the specific activity of the alkaline protease is 100000-200000U/g, and the dosage ratio of the alkaline protease to the sericin solution is (10-20) g: 1L.
Preferably, in step S2, the temperature of the first hydrolysis reaction is 40 to 50 ℃ and the reaction time is 2 to 4 hours.
Preferably, in step S2, the specific activity of the elastase is 3000-8000U/g, and the dosage ratio of the elastase to the first reaction solution is (0.5-2) g: 1L.
Preferably, in step S2, the temperature of the second hydrolysis reaction is 35-40 ℃ and the reaction time is 24-48 h.
Preferably, in step S3, the polyphosphoric acid, sericin, soybean lecithin and water are added in a ratio of (10-20) mL (0.5-0.8) g (5-20) mg (90-180) mL.
The invention also provides a calcium nutritional supplement prepared by the preparation method.
Compared with the prior art, the invention has the following beneficial effects:
the mol nitrogen-phosphorus ratio of the calcium nutritional supplement is as low as 5.21mol/mol, the calcium holding amount is as high as 0.0136g/g, and experimental results show that the calcium absorption rate and the calcium retention rate of a mouse eating the calcium nutritional supplement are obviously improved, which shows that the calcium nutritional supplement has stronger calcium carrying capacity and calcium absorption promoting capacity.
Detailed Description
The invention will be better understood from the following examples. However, those skilled in the art will readily appreciate that the description of the embodiments is only for illustrating the present invention and should not be taken as limiting the invention as detailed in the claims.
The invention provides a preparation method of a calcium nutritional supplement, which comprises the following specific steps:
firstly, boiling silkworm cocoons or waste raw silks with sodium carbonate solution in water to obtain sericin solution, wherein the concentration of the adopted sodium carbonate solution is preferably 50-100g/L, the bath ratio of water boiling is preferably 1:40-1:60, and the time of water boiling is preferably 30-60 min.
And then adding alkaline protease into the obtained sericin solution to perform a first-step hydrolysis reaction to obtain a first reaction solution, adjusting the pH of the first reaction solution to 7.5 by using 6mol/L hydrochloric acid, adding elastase to perform a second-step hydrolysis reaction, performing ultrafiltration, and performing spray drying on the ultrafiltration-obtained permeate to obtain sericin peptide. In this step, the specific activity of the alkaline protease is preferably 100000-; the specific activity of the adopted elastase is preferably 3000-8000U/g, and the adding amount of the elastase is preferably 0.5-2g added into 1L of the first reaction liquid. The temperature of the hydrolysis reaction is preferably 40-50 ℃ and the time of the hydrolysis reaction is preferably 2-4 hours during the first hydrolysis reaction, and the temperature of the hydrolysis reaction is preferably 35-40 ℃ and the time of the hydrolysis reaction is preferably 24-48 hours during the second hydrolysis reaction.
The sericin prepared by the method has a large amount of serine residues, wherein the mass fraction of serine in the total sericin is more than 20%, which is far higher than that of other proteins such as casein, and the serine residues can be combined with calcium after phosphorylation, so that the sericin with high serine content has a low nitrogen-phosphorus ratio, and the calcium combining capability is greatly improved. In addition, the sericin peptide also contains a large amount of aspartic acid, the content of which reaches 14 percent, which is beneficial to improving the water solubility and is easier to be absorbed by organisms.
After sericin is obtained, dropwisely adding polyphosphoric acid onto the sericin, adding soybean lecithin, reacting for 5-8h at 20-50 ℃, adding water after the reaction is finished, cooling to room temperature after 20-30min in a boiling water bath, slowly dropwisely adding a saturated calcium hydroxide solution, fully stirring to determine the pH value, stopping adding the saturated calcium hydroxide solution when the pH value is increased and then reduced to 7.5, cooling to 4-8 ℃, centrifuging, taking a supernatant, and spray drying to obtain the calcium nutritional supplement. In the process, the ratio of the added amount of the polyphosphoric acid, the sericin peptide, the soybean lecithin and the water is preferably (10-20) mL, (0.5-0.8) g, (5-20) mg, (90-180) mL.
In the invention, unreacted polyphosphoric acid can be decomposed into orthophosphoric acid in the boiling water bath process, the added saturated calcium hydroxide solution can be used as a calcium donor, and the orthophosphoric acid in the solution can be converted into calcium phosphate precipitate to be removed, so that excessive phosphoric acid in the system is prevented from antagonizing calcium absorption.
The invention also provides a calcium nutritional supplement prepared by the preparation method.
To further illustrate the present invention, a calcium supplement and a method for preparing the same are described in detail below with reference to examples.
Example 1
(1) Boiling silkworm cocoon with 75g/L sodium carbonate solution in water at a bath ratio of 1:50 for 50min to obtain sericin solution.
(2) Taking 100mL of the sericin solution prepared in the step (1), adding 1.5g of alkaline protease with the specific activity of 150000U/g, and reacting at 45 ℃ for 3h to obtain a first reaction solution. Adjusting pH of the first reaction solution to 7.5 with 6mol/L hydrochloric acid, adding 0.12g of elastase with specific activity of 6000U/g, reacting at 38 deg.C for 36h, ultrafiltering, and spray drying the filtrate obtained by ultrafiltration to obtain sericin peptide.
(3) And (3) dropwise adding 15mL of polyphosphoric acid onto 0.6g of sericin peptide prepared in the step (2), adding 12mg of soybean lecithin, reacting at 37 ℃ for 6h, adding 130mL of water after the reaction is finished, cooling to room temperature after 25min in a boiling water bath, adding a saturated calcium hydroxide solution, slowly dropwise adding a saturated calcium hydroxide solution, fully stirring to determine the pH value, stopping adding the saturated calcium hydroxide solution when the pH value is increased and then reduced to 7.5, cooling to 6 ℃, centrifuging, taking a supernatant, and performing spray drying to obtain the calcium nutritional supplement.
Example 2
(1) Boiling waste raw silk with 50g/L sodium carbonate solution for 30min at a bath ratio of 1:40 to obtain sericin solution.
(2) And (2) taking 100mL of the sericin solution prepared in the step (1), adding 1g of alkaline protease with specific activity of 100000U/g, and reacting at 50 ℃ for 4 hours to obtain a first reaction solution. Adjusting pH of the first reaction solution to 7.5 with 6mol/L hydrochloric acid, adding 0.05g of elastase with specific activity of 3000U/g, reacting at 35 deg.C for 24h, ultrafiltering, and spray drying the filtrate obtained by ultrafiltration to obtain sericin peptide.
(3) And (3) dropwise adding 10mL of polyphosphoric acid onto 0.5g of sericin peptide prepared in the step (2), adding 5mg of soybean lecithin, reacting for 5 hours at 20 ℃, adding 90mL of water after the reaction is finished, cooling to room temperature after 20min of boiling water bath, slowly dropwise adding a saturated calcium hydroxide solution, fully stirring to measure the pH value, stopping adding the saturated calcium hydroxide solution when the pH value is increased and then reduced to 7.5, cooling to 4 ℃, centrifuging, taking a supernatant, and performing spray drying to obtain the calcium nutritional supplement.
Example 3
(1) Boiling waste raw silk with 100g/L sodium carbonate solution for 60min at bath ratio of 1:60 to obtain sericin solution.
(2) Taking 100mL of the sericin solution prepared in the step (1), adding 2g of alkaline protease with the specific activity of 200000U/g, and reacting for 2h at 40 ℃ to obtain a first reaction solution. Adjusting pH of the first reaction solution to 7.5 with 6mol/L hydrochloric acid, adding 0.2g of elastase with specific activity of 8000U/g, reacting at 40 deg.C for 48 hr, ultrafiltering, and spray drying the filtrate to obtain sericin peptide.
(3) And (3) dropwise adding 20mL of polyphosphoric acid onto 0.8g of sericin peptide prepared in the step (2), adding 20mg of soybean lecithin, reacting for 8 hours at 50 ℃, adding 180mL of water after the reaction is finished, cooling to room temperature after 30min of boiling water bath, slowly dropwise adding a saturated calcium hydroxide solution, fully stirring to measure the pH value, stopping adding the saturated calcium hydroxide solution when the pH value is increased and then reduced to 7.5, cooling to 8 ℃, centrifuging, taking a supernatant, and performing spray drying to obtain the calcium nutritional supplement.
Comparative example 1 (phosphorus oxychloride instead of polyphosphoric acid)
(1) Boiling silkworm cocoon with 75g/L sodium carbonate solution in water at a bath ratio of 1:50 for 50min to obtain sericin solution.
(2) Taking 100mL of the sericin solution prepared in the step (1), adding 1.5g of alkaline protease with the specific activity of 150000U/g, and reacting at 45 ℃ for 3h to obtain a first reaction solution. Adjusting pH of the first reaction solution to 7.5 with 6mol/L hydrochloric acid, adding 0.12g of elastase with specific activity of 6000U/g, reacting at 38 deg.C for 36h, ultrafiltering, and spray drying the filtrate obtained by ultrafiltration to obtain sericin peptide.
(3) And (3) dropwise adding 15mL of phosphorus oxychloride on 0.6g of sericin peptide prepared in the step (2), adding 12mg of soybean lecithin, reacting at 37 ℃ for 6h, adding 130mL of water after the reaction is finished, cooling to room temperature after 25min in a boiling water bath, slowly dropwise adding a saturated calcium hydroxide solution, fully stirring to measure the pH value, stopping adding the saturated calcium hydroxide solution when the pH value is increased and then reduced to 7.5, cooling to 6 ℃, centrifuging, taking a supernatant, and performing spray drying to obtain the calcium nutritional supplement.
Comparative example 2 (without alkaline protease treatment)
(1) Boiling waste raw silk with 75g/L sodium carbonate solution for 50min at a bath ratio of 1:50 to obtain sericin solution.
(2) And (2) taking 100mL of the sericin solution prepared in the step (1), adjusting the pH to 7.5 by using 6mol/L hydrochloric acid, adding 0.12g of elastase with the specific activity of 6000U/g, reacting for 36h at 38 ℃, performing ultrafiltration, and performing spray drying on the filtrate obtained by ultrafiltration to obtain sericin peptide.
(3) And (3) dropwise adding 15mL of polyphosphoric acid onto 0.6g of sericin peptide prepared in the step (2), adding 12mg of soybean lecithin, reacting at 37 ℃ for 6h, adding 130mL of water after the reaction is finished, cooling to room temperature after 25min in a boiling water bath, slowly dropwise adding a saturated calcium hydroxide solution, fully stirring to measure the pH value, stopping adding the saturated calcium hydroxide solution when the pH value is increased and then reduced to 7.5, cooling to 6 ℃, centrifuging, taking a supernatant, and performing spray drying to obtain the calcium nutritional supplement.
Comparative example 3 (without Elastase treatment)
(1) Boiling waste raw silk with 75g/L sodium carbonate solution for 50min at a bath ratio of 1:50 to obtain sericin solution.
(2) And (2) taking 100mL of the sericin solution prepared in the step (1), adding 1.5g of alkaline protease with the specific activity of 150000U/g, reacting at 45 ℃ for 3 hours, then carrying out ultrafiltration, and carrying out spray drying on the filtrate obtained by ultrafiltration to obtain the sericin peptide.
(3) And (3) dropwise adding 15mL of polyphosphoric acid onto 0.6g of sericin peptide prepared in the step (2), adding 12mg of soybean lecithin, reacting at 37 ℃ for 6h, adding 130mL of water after the reaction is finished, cooling to room temperature after 25min in a boiling water bath, adding a saturated calcium hydroxide solution, slowly dropwise adding a saturated calcium hydroxide solution, fully stirring to determine the pH value, stopping adding the saturated calcium hydroxide solution when the pH value is increased and then reduced to 7.5, cooling to 6 ℃, centrifuging, taking a supernatant, and performing spray drying to obtain the calcium nutritional supplement.
Experimental example 1
Measuring the nitrogen content in the calcium nutritional supplement obtained in the examples 1-3 and the comparative examples 1-3 by using a Kjeldahl method, measuring the total phosphorus and inorganic phosphorus content in the calcium nutritional supplement by using a Fiske-Subbarow phosphorus determination method, and calculating the organic phosphorus content; measuring relative molecular mass (Sephadex G-25, column specification of 100cm × 5.0cm) by gel filtration, and eluting with 0.025mol/L KCl-0.2mol/L HAc solution at 0.2 mL/min; and measuring the in-vitro calcium holding capacity of the calcium nutritional supplement by using an inductively coupled plasma emission spectrometer. The results of the measurements of nitrogen content, organic phosphorus content, molar nitrogen-phosphorus ratio, relative molecular mass, and calcium holding amount of the calcium supplement are shown in table 1.
TABLE 1 determination of calcium nutritional supplements
As can be seen from table 1, as the molar nitrogen-phosphorus ratio of the calcium supplement decreases, its calcium-holding capacity gradually increases. The calcium holding amount of the calcium nutritional supplements prepared in the examples 1-3 is obviously higher than that of the calcium nutritional supplements prepared in the comparative examples 1-3. Due to the lack of a protease in the preparation methods of comparative example 2 and comparative example 3, the sericin is not hydrolyzed completely, and the molecular weight of the calcium nutritional supplement is obviously larger.
Experimental example 2
The effect of the calcium nutritional supplement of the invention on calcium absorption in mice:
1) test samples: the calcium nutritional supplements prepared in examples 1-3 of the present invention, the calcium nutritional supplements prepared in comparative examples 1-3, and commercially available casein phosphopeptides.
2) Test animals: 80 weaned mice born at 14d have half of the male and female bodies and good health condition.
3) The test method comprises the following steps: after experimental mice are fed for 4 days in an adaptive mode, the experimental mice are randomly divided into 8 groups, 10 mice in each group are half female and half male, the 8 groups of mice are respectively fed into polyethylene plastic boxes according to the group and the sex, the mice freely eat 2-week basic low-calcium feed, and the mice freely drink deionized water to serve as a dead-time period. After the depletion period, 4 weeks of growth experiments were performed during which the groups were fed as follows:
experiment group I: feeding the mice with basal low-calcium feed;
experiment II group: feeding the mice with a basal low-calcium feed mixed with 20% by mass of the calcium nutritional supplement prepared in example 1;
experiment group III: feeding the mice with a basal low-calcium feed mixed with 20% by mass of the calcium nutritional supplement prepared in example 2;
experiment group IV: feeding the mice with a basal low-calcium feed mixed with 20% by mass of the calcium nutritional supplement prepared in example 3;
experiment group V: feeding mice with a basal low-calcium feed mixed with 20% by mass of a commercially available casein phosphopeptide;
experiment group VI: feeding the mice with a basic low-calcium feed mixed with 20% by mass of the calcium supplement prepared in comparative example 1;
experiment group VII: feeding the mice with a basic low-calcium feed mixed with 20% by mass of the calcium supplement prepared in comparative example 2;
experiment group VIII: the mice were fed a basal low-calcium feed mixed with 20% by mass of the calcium nutritional supplement prepared in comparative example 3.
And (3) carrying out a metabolism experiment in the last 3d of the growth experiment, measuring feed calcium, fecal calcium and urinary calcium, and calculating the absorption rate and the retention rate of calcium according to a formula:
the content of the fecal calcium, the urine calcium and the feed calcium is measured according to the GB12398-90 method by adopting an atomic absorption spectrophotometer, and the result is shown in table 2.
TABLE 2 Effect of the calcium supplement of the present invention on calcium absorption in mice
Experimental group | Sample (I) | Calcium absorption rate (%) | Calcium retention rate (%) |
Experiment group I | Low calcium feeding control | 20.1±4.3 | 22.5±4.2 |
Experiment II group | Example 1 | 93.4±2.5 | 92.4±2.1 |
Experiment group III | Example 2 | 89.7±2.0 | 94.0±0.9 |
Experiment group IV | Example 3 | 91.8±1.4 | 90.3±3.3 |
Experiment group V | Casein phosphopeptides commercially available | 69.3±3.4 | 82.4±2.7 |
Experiment group VI | Comparative example 1 | 49.0±4.6 | 57.1±1.9 |
Experiment group VII | Comparative example 2 | 42.1±2.7 | 56.3±5.3 |
Experiment group VIII | Comparative example 3 | 52.7±5.2 | 44.0±3.7 |
As shown in the results of Table 2, the calcium supplement prepared in examples 1 to 3 of the present invention can enhance the absorption and retention of calcium in vivo, and has better effect than the calcium supplement prepared in the commercial casein phosphopeptide and comparative examples 1 to 3.
The present invention provides a calcium supplement and a method for preparing the same, and a plurality of methods and ways for implementing the technical scheme, and the above description is only a preferred embodiment of the present invention, and it should be noted that, for those skilled in the art, a plurality of modifications and decorations can be made without departing from the principle of the present invention, and these modifications and decorations should also be regarded as the protection scope of the present invention. All the components not specified in the present embodiment can be realized by the prior art.
Claims (8)
1. A method for preparing a calcium nutritional supplement, comprising the steps of:
s1, boiling silkworm cocoons or waste raw silks with sodium carbonate solution to obtain a sericin solution;
s2, adding alkaline protease into the sericin solution to perform a first-step hydrolysis reaction to obtain a first reaction solution, adjusting the pH of the first reaction solution to 7.5 by using 6mol/L hydrochloric acid, adding elastase to perform a second-step hydrolysis reaction, performing ultrafiltration, and performing spray drying on a permeate obtained by ultrafiltration to obtain sericin;
s3, dripping polyphosphoric acid on the sericin peptide, adding soybean lecithin, reacting for 5-8h at 20-50 ℃, adding water after the reaction is finished, cooling to room temperature after 20-30min of boiling water bath, slowly dripping saturated calcium hydroxide solution, fully stirring to determine the pH value, stopping adding the saturated calcium hydroxide solution when the pH value is increased and then reduced to 7.5, cooling to 4-8 ℃, centrifuging, taking supernate, and spray drying to obtain the calcium nutritional supplement.
2. The method for preparing a calcium supplement, according to claim 1, wherein in step S1, the concentration of the sodium carbonate solution is 50-100g/L, the bath ratio of water boiling is 1:40-1:60, and the time of water boiling is 30-60 min.
3. The method as claimed in claim 1, wherein in step S2, the specific activity of the alkaline protease is 100000-200000U/g, and the ratio of the alkaline protease to the sericin solution is (10-20) g: 1L.
4. The method for preparing calcium supplement of claim 1, wherein the first hydrolysis reaction is performed at a temperature of 40-50 ℃ for 2-4h in step S2.
5. The method as claimed in claim 1, wherein in step S2, the specific activity of elastase is 3000-8000U/g, and the ratio of the elastase to the first reaction solution is (0.5-2) g: 1L.
6. The method for preparing calcium supplement of claim 1, wherein the second hydrolysis reaction is performed at 35-40 ℃ for 24-48h in step S2.
7. The method of claim 1, wherein the polyphosphoric acid, the sericin, the soybean lecithin and the water are added in a ratio of (10-20) mL (0.5-0.8) g (5-20) mg (90-180) mL in step S3.
8. A calcium nutritional supplement prepared by the preparation method according to any one of claims 1 to 7.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010435331.3A CN111528480B (en) | 2020-05-21 | 2020-05-21 | Calcium nutrition supplement and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010435331.3A CN111528480B (en) | 2020-05-21 | 2020-05-21 | Calcium nutrition supplement and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111528480A true CN111528480A (en) | 2020-08-14 |
CN111528480B CN111528480B (en) | 2023-07-04 |
Family
ID=71969401
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010435331.3A Active CN111528480B (en) | 2020-05-21 | 2020-05-21 | Calcium nutrition supplement and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111528480B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110179127A (en) * | 2019-06-25 | 2019-08-30 | 南通大学 | A kind of nutrition fortifier and preparation method promoting iron zinc calcium uptake |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1748571A (en) * | 2005-10-13 | 2006-03-22 | 杭州康源食品科技有限公司 | Calcium supplementing health food base materials |
CN101965982A (en) * | 2010-10-26 | 2011-02-09 | 曹新志 | Method for preparing beverage from silk peptide |
CN103571905A (en) * | 2013-10-30 | 2014-02-12 | 广州绿萃生物科技有限公司 | Preparation method of high-purity casein phosphopeptide |
CN104232719A (en) * | 2014-09-30 | 2014-12-24 | 中国海洋大学 | Method for preparing calcium chelated peptide |
CN104297184A (en) * | 2014-10-24 | 2015-01-21 | 西安莹朴生物科技股份有限公司 | Method for detecting calcium retention capability of casein phosphopeptides products |
CN107937460A (en) * | 2016-10-13 | 2018-04-20 | 宜宾屏山辉瑞油脂有限公司 | A kind of preparation method for hydrolyzing sericin peptide taken |
CN108866134A (en) * | 2018-07-13 | 2018-11-23 | 广东省农业科学院蚕业与农产品加工研究所 | A kind of chelated calcium preparation method of silkworm pupa protein polypeptide |
CN110179127A (en) * | 2019-06-25 | 2019-08-30 | 南通大学 | A kind of nutrition fortifier and preparation method promoting iron zinc calcium uptake |
CN110353272A (en) * | 2019-07-11 | 2019-10-22 | 南通大学 | A kind of preparation method of calcium-nutrition intensifying agent |
CN110483622A (en) * | 2019-08-26 | 2019-11-22 | 无限极(中国)有限公司 | Casein phosphopeptide and preparation method thereof, application |
CN110499350A (en) * | 2019-03-15 | 2019-11-26 | 辽东学院 | A kind of sericin method for hydrolysis and products thereof and application |
-
2020
- 2020-05-21 CN CN202010435331.3A patent/CN111528480B/en active Active
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1748571A (en) * | 2005-10-13 | 2006-03-22 | 杭州康源食品科技有限公司 | Calcium supplementing health food base materials |
CN101965982A (en) * | 2010-10-26 | 2011-02-09 | 曹新志 | Method for preparing beverage from silk peptide |
CN103571905A (en) * | 2013-10-30 | 2014-02-12 | 广州绿萃生物科技有限公司 | Preparation method of high-purity casein phosphopeptide |
CN104232719A (en) * | 2014-09-30 | 2014-12-24 | 中国海洋大学 | Method for preparing calcium chelated peptide |
CN104297184A (en) * | 2014-10-24 | 2015-01-21 | 西安莹朴生物科技股份有限公司 | Method for detecting calcium retention capability of casein phosphopeptides products |
CN107937460A (en) * | 2016-10-13 | 2018-04-20 | 宜宾屏山辉瑞油脂有限公司 | A kind of preparation method for hydrolyzing sericin peptide taken |
CN108866134A (en) * | 2018-07-13 | 2018-11-23 | 广东省农业科学院蚕业与农产品加工研究所 | A kind of chelated calcium preparation method of silkworm pupa protein polypeptide |
CN110499350A (en) * | 2019-03-15 | 2019-11-26 | 辽东学院 | A kind of sericin method for hydrolysis and products thereof and application |
CN110179127A (en) * | 2019-06-25 | 2019-08-30 | 南通大学 | A kind of nutrition fortifier and preparation method promoting iron zinc calcium uptake |
CN110353272A (en) * | 2019-07-11 | 2019-10-22 | 南通大学 | A kind of preparation method of calcium-nutrition intensifying agent |
CN110483622A (en) * | 2019-08-26 | 2019-11-22 | 无限极(中国)有限公司 | Casein phosphopeptide and preparation method thereof, application |
Non-Patent Citations (2)
Title |
---|
刘冬等: "丝素肽酶法生产工艺条件研究", 《食品与发酵工业》 * |
程霜,等: "蚕丝的食用研究", 《聊城师院学报(自然科学版)》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110179127A (en) * | 2019-06-25 | 2019-08-30 | 南通大学 | A kind of nutrition fortifier and preparation method promoting iron zinc calcium uptake |
CN110179127B (en) * | 2019-06-25 | 2022-04-22 | 南通大学 | Nutrient supplement for promoting absorption of iron, zinc and calcium and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN111528480B (en) | 2023-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5698724A (en) | Amino acid metal complexes using hydrolyzed protein as the amino acid source and methods re same | |
CN102626180B (en) | Amino acid chelating compound organic feed additive and production method thereof | |
CA2002558C (en) | Copper complexes of alpha-amino acids that contain terminal amino acid groups, and their use as nutritional supplements | |
US4103003A (en) | Composition for improving biologic development | |
CN102174073A (en) | Oyster protein peptide and zinc chelate and method for preparing same | |
CN101302171A (en) | Production process of pure amino acid chelate and use thereof | |
CN101283805B (en) | Zinc-polypeptides complex and its preparation method and application | |
CN101289412B (en) | Method for preparing chelates of zinc threonine | |
EP1064853B1 (en) | Fine granular feeds for fry | |
CN111528480B (en) | Calcium nutrition supplement and preparation method thereof | |
KR101683150B1 (en) | Method of manufacturing calcium citrate with high degree of electrolytic dissociation | |
CN106243176B (en) | The copper complex formazan preparation method of sucrose | |
RU2465783C1 (en) | Preliminarily prepared fodder mixture containing multiple microelements and mixture production method | |
CN101289411B (en) | Method for preparing zinc threonine | |
JPH05219897A (en) | Galactooligosaccharide-containing feed | |
Grudina et al. | New type of food additives based on polymers | |
CN115005337A (en) | Special artificial milk for piglet in sterility test and preparation method thereof | |
CN110179127B (en) | Nutrient supplement for promoting absorption of iron, zinc and calcium and preparation method thereof | |
KR100493851B1 (en) | Hydrolyzed yeast containing high concentration of selenium, preparing method thereof, and functional additives for livestock containing the same | |
CN113841795A (en) | Self-assembled small peptide chelated copper feed additive and preparation method thereof | |
CN105254683A (en) | Alpha-type xylooligosaccharide and preparation method and applications thereof | |
CN101139300A (en) | Method for preparing copper zinc aminoacetic acid complex by grinding solid phase | |
CN109824880B (en) | Beta-polymaleate and preparation method and application thereof | |
CN1059321C (en) | Iron, cobalt, selenophene, copper, arsenic injection | |
CN114317656B (en) | Bioactive hairtail peptide microelement chelate and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |